Menu

Материалы с тегом "Pfizer"

27 October 2021

18:30

The advantages outweighed the risks: FDA officials back Pfizer jab for children over five in the United States

A US government panel has voted to recommend the Pfizer/BioNTech vaccine should to be given to children aged five to 11.

20 October 2021

22:17

Third booster dose of COVID-19 vaccine: 50-fold jump in antibodies after a third shot in Israel

Israeli scientists have confirmed the high effectiveness of the third dose of the coronavirus vaccine.

24 July 2021

14:27

Pfizer and AstraZeneca COVID-19 vaccines’ effectiveness against Delta variant: study results

Two doses of Pfizer or AstraZeneca coronavirus vaccineare highly effective against the Delta strain, which is now the dominant COVID-19 variant in the world.

5 July 2021

11:33

Pfizer reacted to the report of death of a Ukrainian citizen after a COVID vaccination

The coronavirus vaccine manufacturer, Pfizer/BioNTech, reacted to the death of a 47-year-old Ukrainian a few hours after he received a shot of a Pfizer coronavirus vaccine on July 2, 2021.

10 May 2021

20:54

BioNTech made a statement regarding the effectiveness of its COVID-19 vaccine against different coronavirus strains

The Pfizer-BioNTech coronavirus vaccine does not require any modifications to ensure the protection against new strains of COVID-19.This was stated in a statementpublished by BioNTech.

1 May 2021

14:37

Ukraine shall receive additional 10 million doses of the Pfizer vaccine

Ukraine has signed a contract with the American pharmaceutical company Pfizer on the supply of additional 10 million doses of COVID-19 vaccine.

2 April 2021

00:10

Pfizer summed up the results of vaccination for six months

The Pfizer/BioNTech COVID-19 vaccine was able to prove its effectiveness within six months vaccinating period.

24 March 2021

07:12

Pfizer initiates phase 1 study of the novel oral antiviral therapeutic drug against COVID-19

The American company Pfizer Inc, which has created a vaccine against COVID-19, announced that it is progressing to multiple ascending doses after completing the dosing of single ascending doses in a Phase 1 study in healthy adults to evaluate the safety and tolerability of an investigational, novel oral antiviral therapeutic for SARS-CoV-2, the virus that causes COVID-19.

goto top

politics

business

economy

society

world

kyiv

© 2014 – 2024, Apostrophe. Any materials, owned by Internet mass Media “Apostrophe”, may be reproduced only by proving direct link to the web-site. Internet Mass Media shall use direct hyperlink, open for search system, that should be placed in the first or the second paragraph. promo, business case, company news, special project, partnership – content, marked by this symbol, is the advertisement. Advertising providers shall be liable for advertising content.

Developed by: